Trials / Unknown
UnknownNCT06317428
NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
Change in Serum Levels of NT-proBNP During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 29 (estimated)
- Sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Observational prospective study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the iniation of triple inhaled formoterol/glycopyrrolate/budesonide therapy.
Detailed description
The purpose of the trixeo study is to conduct a prospective observational study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the initiation of triple inhaled formoterol/glycopyrrolate/budesonide therapy.
Conditions
Timeline
- Start date
- 2022-06-28
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-03-19
- Last updated
- 2024-03-19
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06317428. Inclusion in this directory is not an endorsement.